|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|
| Revenue: | ||
| Collaboration revenue | ||
| Total revenue | ||
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Gain on disposition | ||
| Other income | ||
| Interest income | ||
| Interest expense | ||
| Total other income (expense), net | ||
| Net loss | ||
| Other comprehensive loss: | ||
| Unrealized loss on investments, net of tax of $0 | ||
| Total other comprehensive loss | ||
| Comprehensive loss | ||
| Cumulative dividends on redeemable convertible preferred stock | ||
| Net loss attributable to common stockholders | ||
| Net loss per share attributable to common stockholders, basic and diluted | ||
| Weighted average common shares outstanding, basic and diluted |
Loading...
